Table 2. Clinicopathological characteristics of study cohort.
Age at first biopsy (yrs, N = 95) | |
Mean (Range) | 3.54 (0.02–10.94) |
Gender (N = 95) | |
Male | 60 |
Female | 35 |
Sample type (N = 118) | |
Pre-treatment primary tumors | 36 |
Post-treatment primary tumors | 53 |
Relapsed/metastatic tumors | 26 |
Treatment status unknown | 3 |
Histology (N = 118) | |
Neuroblastoma | 67 |
Ganglioneuroblastoma | 16 |
Ganglioneuroma | 3 |
Neuroblastic tumor, unspecified | 32 |
MYCN amplification status (N = 108) | |
Amplified | 26 |
Non-amplified | 81 |
Equivocal | 1 |